Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Royalty Pharma plc RPRX

Healthcare Biotechnology
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including... see more

Recent & Breaking News (NDAQ:RPRX)

Royalty Pharma to Announce Second-Quarter 2020 Financial Results on August 12

GlobeNewswire July 20, 2020

Royalty Pharma Acquires Royalty Interest in Risdiplam From PTC Therapeutics

GlobeNewswire July 20, 2020

New Ventures Portfolio Company, ADC Therapeutics, Completes $267 Million IPO

PR Newswire June 30, 2020

New Ventures Portfolio Company, Royalty Pharma, Surges On Public Debut

PR Newswire June 25, 2020

Royalty Pharma Announces Closing of Initial Public Offering

GlobeNewswire June 18, 2020

Repros Announces Negative Opinion From the EMA for Enclomiphene

GlobeNewswire January 26, 2018

Monteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Buffalo Wild Wings Inc. In The District Of Minnesota

PR Newswire January 9, 2018

Lifshitz & Miller LLP Announces Investigation of Almost Family, Inc., FNB Bancorp, Repros Therapeutics Inc., Snyder's-Lance, Inc., Southcross Energy Partners, L.P., Stone Energy Corporation and Tableau Software, Inc.

PR Newswire December 28, 2017

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Repros Therapeutics, Inc. - RPRX

PR Newswire December 18, 2017

Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency

GlobeNewswire December 15, 2017

REPROS THERAPEUTICS INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout

Business Wire December 12, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of FNB Bancorp. to TriCo Bancshares is Fair to Shareholders – FNBG

Business Wire December 12, 2017

A Peek Into The Markets: U.S. Stock Futures Mostly Higher Ahead Of Fed Meeting

Benzinga.com  December 12, 2017

Repros Therapeutics Inc.® Announces Acquisition by Allergan plc

GlobeNewswire December 12, 2017

Repros Therapeutics Inc.® Reports Third Quarter 2017 Financial Results

GlobeNewswire November 13, 2017

32 Biggest Movers From Yesterday

Benzinga.com  October 18, 2017

Biotech Stocks on Investors' Radar -- Neothetics, Pieris Pharma, and Repros Therapeutics

PR Newswire September 27, 2017

Mid-Afternoon Market Update: Crude Oil Down 2%; Neff Shares Spike Higher

Benzinga.com  August 14, 2017

Repros Therapeutics Inc.® Reports Second Quarter 2017 Financial Results

GlobeNewswire August 14, 2017

Lifshitz & Miller LLP Announces Investigation of Acacia Communications, Inc., AngioDynamics, Inc., ClubCorp Holdings, Inc., HD Supply Holdings, Inc., Ocular Therapeutix, Inc., Repros Therapeutics Inc. and Tahoe Resources Inc.

PR Newswire July 24, 2017